Abstract:Background Obesity has been associated with risk of atrial fibrillation (AF), but once AF is established, it seems to be favorable, which is termed the obesity paradox. However, body mass index (BMI), the commonly used anthropometric marker of obesity does not distinguish between fat and lean body mass, and could lead to the potential misclassification of risk categories. Understanding the role of fat and lean mass might provide new insights into the obesity paradox and promote targeted interventions in AF. Purpose To investigate the associations of BMI, lean body mass, and fat mass with all-cause mortality in patients with AF. Methods A total of 8,325 patients (mean age 62.1±6.07 years) with AF at baseline were included in the prospective cohort study using UK biobank data. Body composition data (fat mass and lean body mass) were estimated using an eight-contact electrode Tanita BC418MA segmental body composition analyser. Cox proportional hazards regression models were used to estimate the above associations. Results During a mean of 13.7 years of follow-up, 2,058 deaths were identified. A U-shaped association was observed between BMI and all-cause mortality. Multivariable adjusted Cox models including fat mass and lean body mass revealed U-shaped associations of fat and lean body mass with all-cause mortality. According to the restricted cubic spline models, the risk of all-cause mortality decreased until around 27 kg/m2 of BMI and increased afterward in both sexes. In women, the average fat mass and lean body mass with 27 kg/m2 of BMI were 27 and 42 kg, respectively. For fat mass, the risk of all-cause mortality decreased up to approximately 27 kg with a hazard ratio (HR) of 0.396 (95% confidence interval 0.383-0.410) per standard deviation (SD), and then increased with a HR of 1.323 (1.320-1.326) per SD. A larger reduction in risk was observed within the lower range until 42 kg of lean body mass with a HR per SD of 0.293 (0.275-0.312), which increased gradually thereafter with HR per SD of 1.174 (1.157-1.192). For men, the average fat mass and lean body mass with 27 kg/m2 of BMI were 22 and 60 kg, respectively. The risk of all-cause mortality decreased up to approximately 22 kg of fat mass with a HR of 0.427 (0.412-0.441) per SD, and then increased with a HR of 1.353 (1.348-1.359) per SD. A similar trend of risk reduction was observed until 60 kg of lean body mass [HR (0.443, 0.433-0.454) per SD], which increased gradually thereafter with HR per SD of 1.165 (1.162-1.167). Conclusion Our findings suggest that the associations between between fat and lean body mass, and mortality determined the shape of the association between BMI and mortality. The "obesity paradox" may be largely explained by both fat and lean body mass in AF. Maintaining healthy body composition is of critical importance to improve prognosis in AF. For patients with BMI ≥ 27 kg/m2, more emphasis should be placed on reducing fat mass than lean mass.Associations of BMI, WC, WHtR with deathAssociations of fat/lean mass with death

Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity

Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

Global Trend in Overweight and Obesity and Its Association with Cardiovascular Disease Incidence.

Body-Mass Index and All-Cause Mortality: Individual-Participant-Data Meta-Analysis of 239 Prospective Studies in Four Continents

Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults During 1980-2013: A Systematic Analysis for the Global Burden of Disease Study 2013

Health Effects of Overweight and Obesity in 195 Countries.

Obesity paradox of cardiovascular mortality in older adults in the United States: A cohort study using 1997–2018 National Health Interview Survey Data Linked with the National Death Index

Obesity and Cardiovascular Disease

Abstract 11459: The Biochemical and Physiological Pathways From Obesity to Cardiovascular Disease: A Prospective Cohort Study of 404332 UK Biobank Participants

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality

Abstract EP43: Obesity And Incident Cardiovascular Disease (CVD): The Jackson Heart Study

Rising Obesity-Associated Mortality in Men: Exploration of Gender Disparity from the Global Burden of Disease Study, 1990–2019

Ambulatory Blood Pressure Monitoring for Risk Stratification in Obese and Non-Obese Subjects from 10 Populations.

Impact of Obesity on All-Cause and Cause-Specific Mortality among Critically Ill Men and Women: a Cohort Study on the Eicu Database

Association of Central Obesity With All Cause and Cause-Specific Mortality in US Adults: A Prospective Cohort Study

Revisiting the obesity paradox: lean body mass, fat mass, and mortality in patients with atrial fibrillation

Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly

Obesity paradox and cardiovascular risk

Obesity and cardiovascular disease: an ESC clinical consensus statement

Trends in all-cause and cause-specific mortality by BMI levels in England, 2004-2019: a population-based primary care records study